logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

BupivacaineCompartment syndrome following an off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2017年 / 1644卷 / 1期
关键词:
D O I:
10.1007/s40278-017-27833-2
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:61 / 61
相关论文
共 50 条
  • [21] TocilizumabNeutropenia following off-label use: case report
    Reactions Weekly, 2021, 1853 (1) : 446 - 446
  • [22] SunitinibCardiomyopathy following off-label use: case report
    Reactions Weekly, 2023, 1971 (1) : 240 - 240
  • [23] PrednisoloneInefficacy following off-label use: case report
    Reactions Weekly, 2022, 1910 (1) : 405 - 405
  • [24] DaratumumabHypogammaglobulinemia following off-label use: case report
    Reactions Weekly, 2019, 1744 (1) : 111 - 111
  • [25] NivolumabPsoriasis following an off-label use: case report
    Reactions Weekly, 2018, 1717 (1) : 214 - 214
  • [26] GlibenclamideHypoglycaemia following off-label use: case report
    Reactions Weekly, 2021, 1857 (1) : 162 - 162
  • [27] CatequentinibPneumothorax following off-label use: case report
    Reactions Weekly, 2022, 1925 (1) : 158 - 158
  • [28] TolvaptanHypernatraemia following off-label use: case report
    Reactions Weekly, 2019, 1753 (1) : 326 - 326
  • [29] FelbamateNeutropenia following off-label use: case report
    Reactions Weekly, 2020, 1803 (1) : 111 - 111
  • [30] MethylprednisoloneFungaemia following an off-label use: case report
    Reactions Weekly, 2022, 1899 (1) : 243 - 243
← 12345 →